The goal of this study was to evaluate the effects of a mixture of yeast culture, cell wall hydrolysates, and yeast extracts（collectively ＂yeast products,＂ YP） on the performance, intestinal physiology, and health...The goal of this study was to evaluate the effects of a mixture of yeast culture, cell wall hydrolysates, and yeast extracts（collectively ＂yeast products,＂ YP） on the performance, intestinal physiology, and health of weaned piglets. A total of 90 piglets weaned at 21 d of age were blocked by body weight, sex, and litter and randomly assigned to one of three treatments for a 14-d feeding experiment, including（1） a basal diet（control）,（2） 1.2 g/kg of YP, and（3） 20 mg/kg of colistin sulfate（CSE）. No statistically significant differences were observed in average daily feed intake, average daily weight gain, or gain-to-feed ratio among CSE, YP, and control piglets. Increased prevalence of diarrhea was observed among piglets fed the YP diet, whereas diarrhea was less prevalent among those fed CSE. Duodenal and jejunal villus height and duodenal crypt depth were greater in the control group than they were in the YP or CSE groups. Intraepithelial lymphocytes（IEL） in the duodenal and jejunal villi were enhanced by YP, whereas IEL in the ileal villi were reduced in weaned piglets fed YP. Secretion of jejunal and ileal interleukin-10（IL-10） was higher and intestinal and serum antioxidant indexes were affected by YP and CSE. In YP- and CSE-supplemented animals, serum D-lactate concentration and diamine oxidase（DAO） activity were both increased, and intestinal mR NA expressions of occludin and ZO-1 were reduced as compared to the control animals. In conclusion, YP supplementation in the diets of weaned piglets appears to increase the incidence of diarrhea and has adverse effects on intestinal morphology and barrier function.展开更多
Objective:The objective of this study is to screen the therapeutic targets of pain of traditional Chinese medicine Chonglou and explore the relevant mechanism by network pharmacology techniques and methods.Materials a...Objective:The objective of this study is to screen the therapeutic targets of pain of traditional Chinese medicine Chonglou and explore the relevant mechanism by network pharmacology techniques and methods.Materials and Methods:The chemical components of Chonglou were collected according to chemistry database and related literature.SwissADME was used to collect the potential active ingredients from all the chemical components of Chonglou and SwissTarget Prediction was utilized to predict their targets.The genes related to pain were collected from GeneCards and Online Mendelian Inheritance in Man databases.Joint genes were uploaded to the online string database for the analysis and the PPI network was constructed.The"Chonglou-active component-target-pain"network was constructed by Cytoscape 3.7.1 software,Gene Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis were performed for key target proteins.The top three active components with most targets in the network were docked with the target proteins by the molecular docking technique.Results:A total of nine potential active compounds of Chonglou,264 potential target genes,2385 targets of pain disorder,and 128 common targets for drug and disease were screened.One hundred and thirty-one GO items were identified by the GO enrichment analysis,and 23 related signaling pathways were identified by the KEGG pathway enrichment analysis.Molecular-docking results show that pennogenin is the optimal butt ligand of PIK3 CA,STAT3,mitogen-activated protein kinase 14,and ADORA1.Conclusion:It is preliminarily revealed that Chonglou might treat pain through multiple targets,multiple biology processes and multiple pain-related signaling pathways,providing reference for the subsequent experimental research.展开更多
基金supported by the National Natural Science Foundation of China(Nos.31330075,31402089,31301988,31572420,31272450,and 31272451)the National Key Technology R&D Program of China(No.2016YFD0500504)+2 种基金the Changsha Lvye Biotechnology Limited Company Academician Expert Workstationthe Guangdong Hinapharm Group Academician Workstation for Biological Feed and Feed Additivesthe Animal Intestinal Health Hunan New Wellful Co.,Ltd.,Academician Workstation,Changsha,China
文摘The goal of this study was to evaluate the effects of a mixture of yeast culture, cell wall hydrolysates, and yeast extracts（collectively ＂yeast products,＂ YP） on the performance, intestinal physiology, and health of weaned piglets. A total of 90 piglets weaned at 21 d of age were blocked by body weight, sex, and litter and randomly assigned to one of three treatments for a 14-d feeding experiment, including（1） a basal diet（control）,（2） 1.2 g/kg of YP, and（3） 20 mg/kg of colistin sulfate（CSE）. No statistically significant differences were observed in average daily feed intake, average daily weight gain, or gain-to-feed ratio among CSE, YP, and control piglets. Increased prevalence of diarrhea was observed among piglets fed the YP diet, whereas diarrhea was less prevalent among those fed CSE. Duodenal and jejunal villus height and duodenal crypt depth were greater in the control group than they were in the YP or CSE groups. Intraepithelial lymphocytes（IEL） in the duodenal and jejunal villi were enhanced by YP, whereas IEL in the ileal villi were reduced in weaned piglets fed YP. Secretion of jejunal and ileal interleukin-10（IL-10） was higher and intestinal and serum antioxidant indexes were affected by YP and CSE. In YP- and CSE-supplemented animals, serum D-lactate concentration and diamine oxidase（DAO） activity were both increased, and intestinal mR NA expressions of occludin and ZO-1 were reduced as compared to the control animals. In conclusion, YP supplementation in the diets of weaned piglets appears to increase the incidence of diarrhea and has adverse effects on intestinal morphology and barrier function.
基金financially supported by Natural Science Foundation of China(No.81861138042)Natural Science Foundation of China(No.81673634)+1 种基金Natural Science Foundation of Shandong,China(No.ZR2019MC004)the high-end talent team construction foundation(No.108-10000318)。
文摘Objective:The objective of this study is to screen the therapeutic targets of pain of traditional Chinese medicine Chonglou and explore the relevant mechanism by network pharmacology techniques and methods.Materials and Methods:The chemical components of Chonglou were collected according to chemistry database and related literature.SwissADME was used to collect the potential active ingredients from all the chemical components of Chonglou and SwissTarget Prediction was utilized to predict their targets.The genes related to pain were collected from GeneCards and Online Mendelian Inheritance in Man databases.Joint genes were uploaded to the online string database for the analysis and the PPI network was constructed.The"Chonglou-active component-target-pain"network was constructed by Cytoscape 3.7.1 software,Gene Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis were performed for key target proteins.The top three active components with most targets in the network were docked with the target proteins by the molecular docking technique.Results:A total of nine potential active compounds of Chonglou,264 potential target genes,2385 targets of pain disorder,and 128 common targets for drug and disease were screened.One hundred and thirty-one GO items were identified by the GO enrichment analysis,and 23 related signaling pathways were identified by the KEGG pathway enrichment analysis.Molecular-docking results show that pennogenin is the optimal butt ligand of PIK3 CA,STAT3,mitogen-activated protein kinase 14,and ADORA1.Conclusion:It is preliminarily revealed that Chonglou might treat pain through multiple targets,multiple biology processes and multiple pain-related signaling pathways,providing reference for the subsequent experimental research.
